期刊文献+

当归补血汤对心力衰竭大鼠心肌组织的影响 被引量:12

Influence of Danggui Buxue Decoction on Cardiac Tissue of Rats with Heart Failure
下载PDF
导出
摘要 目的:探讨当归补血汤对慢性心力衰竭大鼠心肌组织的影响。方法:采用阿霉素腹腔注射建立大鼠心衰模型,再随机将大鼠分为模型对照组,西药组,高剂量当归补血汤(0.5mL)+西药组,低剂量当归补血汤(0.25mL)+西药组。连续灌服42天后,采用酶联免疫吸附法(ELLSA)对以上各组心肌组织的内皮素(ET)和降钙素基因相关肽(CGRP)含量进行测定;并采用硫代巴比妥酸(TBA)比色法和邻苯三酚法测定心肌组织中丙二醛(MDA)和超氧化物歧化酶(SOD)的含量;同时对各组的心脏指数和免疫脏器指数进行了测定。结果:高、低剂量的当归补血汤+西药和单纯西药均能显著提高心衰大鼠心肌组织CGRP和SOD含量(P<0.01),并可明显降低ET和MDA含量(P<0.01);与传统的常规西药相比,高、低剂量的当归补血汤+西药组效果更为显著(P<0.01),同时,它还显著提高心衰大鼠的免疫脏器指数(P<0.01)。结论:当归补血汤可显著加强传统西药改善心力衰竭心肌组织的ET、CGRP、MDA和SOD的作用。 Objective: To explore influence of Danggui Buxue decoction on cardiac tissue of rats with heart failure.Methods: Heart failure model rats were established by using intraperitoneal injection of hydrochloric doxorubicin.Except the model rats,rats were treated by ig conventional medicine and Danggui Buxue decoctionplusconventional medicine,respectively for 45 days,once a day.The major criteria for evaluating the influence of Danggui Buxue decoction on content of endothelin(ET),calcitonin gene-related peptide(CGRP),malondialdehyde(MDA) and superoxide dismutase(SOD) in cardiac tissue.Results: Higher and lower dosages of Danggui Buxue decoctionplusconventional medicine and conventional medicine could significantly increase the concentrations of CGRP and SOD in the cardiac tissue of rats with heart failure(P〈0.01).By contrast,they could significantly decrease ET and MDA levels(P〈0.01).There was a significant difference as compared with the conventional medicine group(P〈0.01).Conclusion: Danggui Buxue decoction intensifies the efficacy of conventional medicine on the cardiac tissue of rats with heart failure through improving ET,CGRP,SOD and MDA.
出处 《中医药学报》 CAS 2013年第3期102-105,共4页 Acta Chinese Medicine and Pharmacology
基金 国家自然科学基金项目(No.81260070) 兰州市科技局项目(No.2011-1-71)
关键词 当归补血汤 心力衰竭 内皮素 降钙素基因相关肽 超氧化物歧化酶 丙二醛 Danggui Buxue decoction Heart failure Endothelin Calcitonin gene-related peptide Superoxide dismutase Malondialdehyde
  • 相关文献

参考文献8

二级参考文献41

  • 1FRET N, KATUS HA, OLSON EN, et al. Hypertrophy of the heart : a new therapeutic target? [ J ]. Circulation,2004,109 ( 13 ) : 1580 - 1589.
  • 2FIEDLER B, WOLLERT KC. Interference of antihypertrophic molecules and signaling pathways with the Ca^2+ -ealcineurin- NFAT cascade in cardiac myocytes [ J]. Cardiovasc Res, 2004, 63(3) :450-457.
  • 3MACDONNELL SM,WEISSER-THOMAS J, KUBO H, et al. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes[J]. CircRes,2009,105(4):316-325.
  • 4HALLHUBER M, BURKARD N, WU R, et al. Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy [ J ]. Circ Res ,2006,99 ( 6 ) :626 - 635.
  • 5VEGA RB, ROTHERMEL BA, WEINHEIMER C J, et al. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy [ J ]. Proc Natl Acad Sci USA, 2003,100 ( 2 ) : 669 - 674.
  • 6ZHANG HG, LI XH,ZHOU JZ,et al. Gotq-protein earboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo[ J ]. Clin Exp Pharmacol Physiol,2007, 34(12) :1276 - 1281.
  • 7WANG XQ, ZHANG HG, CHENG YQ, et al. Inhibition of left ventricular remodelling in spontaneously hypertensive rats by Gαq-protein carboxyl terminus imitation polypeptide GCIP-27 is not entirely dependent on blood pressure[ J]. Clin Exp Pharmacol Physiol,2008, 35(12) :1215 - 1221.
  • 8CANTLEY LC. The phosphoinositide 3-kinase pathway [ J ]. Science,2002,296 ( 5573 ) : 1655 - 1657.
  • 9OUDIT GY, PENNINGER JM. Cardiac regulation by phosphoinositide 3-kinases and PTEN[J]. Cardiovasc Res,2009,82(2) :250 - 260.
  • 10LUO J, MCMULLEN JR, SOBKIW CL,et al. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy [ J ]. Mol Cell Biol,2005,25 ( 21 ) :9491 - 9502.

共引文献75

同被引文献140

引证文献12

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部